Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc., listed under ticker MAAQ, originated as Mana Capital Acquisition Corp, a blank-check company that completed its initial public offering in 2021 with a focus on the healthcare and diagnostics sector. Sponsored by Mana Capital LLC, the vehicle filed a Form 10-Q with the SEC on August 10, 2022, capturing its quarterly financials during the active phase of its announced business combination with Cardio Diagnostics, an AI-powered epigenetic cardiac testing company. The de-SPAC transaction subsequently closed in late 2022, giving the combined entity the Cardio Diagnostics Holdings name. For full filing histories, deal timelines, and sponsor profiles on MAAQ and hundreds of other SPACs, sign up for SpacDesk.